# Waters Corporation

> Waters Corporation supplies laboratory instruments, consumables, informatics and services for pharmaceutical, clinical, food, environmental and materials testing. Its chromatography and mass spectrometry expertise now sits alongside flow cytometry and diagnostic technologies acquired from BD in February 2026.

- **Founded:** 1958
- **Headquarters:** Milford, United States
- **Founders:** James Logan Waters (Founder of Waters Associates, predecessor business)
- **Products:** ACQUITY UPLC, ACQUITY Premier, Alliance iS HPLC, Empower Chromatography Data System, BioAccord LC-MS
- **Notable:** Launched ACQUITY UPLC in 2004., Built an integrated portfolio spanning separation chemistry, instrumentation, informatics and service., Completed the Wyatt Technology acquisition in May 2023.

## Products & services

- **ACQUITY UPLC** — Liquid chromatography systems and columns for high-resolution separations.
- **ACQUITY Premier** — LC systems using MaxPeak High Performance Surfaces to reduce losses of metal-sensitive analytes.
- **Alliance iS HPLC** — Routine HPLC with guided operation and pre-run checks integrated with Empower.
- **Empower Chromatography Data System** — Instrument control, data processing and traceable electronic records; evolved from Millennium software.
- **BioAccord LC-MS** — Integrated LC-MS workflows for biopharmaceutical characterization and monitoring.
- **Xevo TQ Absolute XR IVD** — Clinical tandem quadrupole mass spectrometer introduced for routine IVD laboratory workflows.
- **Andrew+ and OneLab** — Robotic liquid handling and software for preparing and documenting laboratory workflows.
- **Wyatt light scattering and field-flow fractionation** — Instruments and software for molecular and particle characterization; acquired in 2023.
- **Materials science instrumentation** — Thermal analysis, rheology and microcalorimetry products, including the TA Instruments portfolio.
- **Biosciences and advanced diagnostics** — Flow cytometry, reagents, single-cell multiomics, microbiology, molecular diagnostics and point-of-care testing; expanded through the 2026 BD combination.
- **Consumables and laboratory services** — Columns, sample preparation products, standards, maintenance, training and qualification support.

## Achievements

- Launched ACQUITY UPLC in 2004.
- Built an integrated portfolio spanning separation chemistry, instrumentation, informatics and service.
- Completed the Wyatt Technology acquisition in May 2023.
- Completed the BD biosciences and diagnostic solutions combination on February 9, 2026 and established four divisions.

## Latest updates

- **2026-02** — Completed the BD combination; Waters described a workforce of approximately 16,000 colleagues.
- **2026-07** — Launched the Xevo TQ Absolute XR IVD mass spectrometer on July 27.
- **2026-08** — Reported Q2 revenue of $1.645 billion on August 4; organic constant currency revenue growth was 9%, while GAAP diluted loss per share was $1.39.

## Links

- Website: https://www.waters.com/
- LinkedIn: https://www.linkedin.com/company/waters/
- Twitter/X: https://twitter.com/WatersCorp
- YouTube: https://www.youtube.com/waterscorporation
- Facebook: https://www.facebook.com/Waters

---

Profile page: https://yespress.io/waters-corporation
Published by YesPress — https://yespress.io
Last updated: 2026-10-24